A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary Aspergillosis
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The study evaluates the addition of itraconazole to glucocorticoids in management of acute
stages of allergic bronchopulmonary aspergillosis (ABPA). Half of the participants will
receive glucocorticoids while the other half will receive itraconazole and glucocorticoids
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Postgraduate Institute of Medical Education and Research